Behavioural problems in Huntington's disease using the Problem Behaviours Assessment
- PMID: 18291297
- DOI: 10.1016/j.genhosppsych.2007.11.005
Behavioural problems in Huntington's disease using the Problem Behaviours Assessment
Abstract
Objective: To investigate behavioural problems in Huntington's disease (HD).
Method: In 152 HD mutation carriers and a control group of 56 noncarriers at initial 50% risk, the Dutch version of the Problem Behaviours Assessment (PBA) was administered. Mutation carriers were divided into three groups according to the motor section of the Unified Huntington's Disease Rating Scale (UHDRS): pre-(motor) symptomatic, early and advanced symptomatic subjects. The factor structure and interrater reliability of the PBA were investigated.
Results: The clinically relevant interrater reliability of the PBA was 0.82 for severity scores and 0.73 for frequency scores. The PBA showed a three-factor solution: apathy, depression and irritability. Mutation carriers, including presymptomatic subjects, portrayed more apathy, depression and irritability than noncarriers. Early symptomatic subjects had more apathy, but not more depression or irritability, compared to presymptomatic subjects. Advanced symptomatic subjects had more apathy than early symptomatic subjects.
Conclusions: The PBA is a reliable and sensitive instrument. Behavioural problems occur in all stages of HD and arise before the onset of motor symptoms. Apathy is related to disease severity, whereas depression and irritability are not. The broad clinical phenotype of HD therefore requires adequate service delivery with integrated and multidisciplinary patient care.
Similar articles
-
Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.Neurodegener Dis. 2014;13(1):9-16. doi: 10.1159/000343210. Epub 2013 Aug 16. Neurodegener Dis. 2014. PMID: 23948661
-
Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.Arch Neurol. 2007 Jan;64(1):116-21. doi: 10.1001/archneur.64.1.116. Arch Neurol. 2007. PMID: 17210818
-
Measurement of psychopathology in Huntington's disease: the critical role of caregivers.J Nerv Ment Dis. 2010 May;198(5):329-33. doi: 10.1097/NMD.0b013e3181da50d7. J Nerv Ment Dis. 2010. PMID: 20458193
-
Psychiatric features of Huntington's disease: recent approaches and findings.Psychiatr Dev. 1983 Summer;1(2):193-205. Psychiatr Dev. 1983. PMID: 6232607 Review.
-
Neuropsychiatry of Huntington's disease and other basal ganglia disorders.Psychosomatics. 2000 Jan-Feb;41(1):24-30. doi: 10.1016/S0033-3182(00)71170-4. Psychosomatics. 2000. PMID: 10665265 Review.
Cited by
-
Lower Prevalence of Chronic Pain in Manifest Huntington's Disease: A Pilot Observational Study.Brain Sci. 2022 May 21;12(5):676. doi: 10.3390/brainsci12050676. Brain Sci. 2022. PMID: 35625062 Free PMC article.
-
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms.Front Behav Neurosci. 2014 Apr 23;8:135. doi: 10.3389/fnbeh.2014.00135. eCollection 2014. Front Behav Neurosci. 2014. PMID: 24795586 Free PMC article. Review.
-
Occupational performance in Huntington's disease: A cross-sectional study.Br J Occup Ther. 2023 Jun;86(6):432-440. doi: 10.1177/03080226231156523. Epub 2023 Apr 19. Br J Occup Ther. 2023. PMID: 40337090 Free PMC article.
-
Seven-year clinical follow-up of premanifest carriers of Huntington's disease.PLoS Curr. 2011 Nov 30;3:RRN1288. doi: 10.1371/currents.RRN1288. PLoS Curr. 2011. PMID: 22173894 Free PMC article.
-
Assessment Scales for Patients with Advanced Huntington's Disease: Comparison of the UHDRS and UHDRS-FAP.Mov Disord Clin Pract. 2018 Aug 24;5(5):527-533. doi: 10.1002/mdc3.12646. eCollection 2018 Sep-Oct. Mov Disord Clin Pract. 2018. PMID: 30515443 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical